Over the last 180 days, Dermata Therapeutics, Inc. insiders sold a net $13 of stock across 6 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.
Showing the most recent few. Create a free account to see 1 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| OPERATING INCOME | $-7.8M | $-12.5M | $-8.0M | $-9.7M |
| NET INCOME | $-7.6M | $-12.3M | $-7.8M | $-9.6M |
| EPS (DILUTED) | -8.16 | -80.32 | -39.99 | — |
| OPERATING CASH FLOW | $-7.8M | $-11.2M | $-6.4M | $-8.8M |
| CASH | $7.5M | $3.2M | — | $6.2M |
No password to create and no card required. We store your email address and nothing else.